DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
V•••• B••••• I••
Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Nothing material in the last 200 days. No dated change on record yet.
Mark path, consensus per quarter end
100¢ · 90¢ · 100¢ · 100¢ · 100¢Q4 2024 to Q2 2026
Where each lender marks it, 0 points apart
100¢100¢
Principal held
at least $4.9M
sum of BDC pieces, a lower bound
Fair value
$11.2M
100c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
2
2 on the latest quarter
Facilities
4
2 equity pieces beside them
Next maturity
Dec 15, 2031
no dated debt inside 24 months
On the tape since
Dec 31, 2024
latest Jun 30, 2026
Events
4
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| A•••• P•••••• C••••• F•••• L•• | $3.26M | 100¢ | 0 pts |
| A•••• C••••• B•• I••• | $1.59M | 100¢ | 0 pts |
Every BDC piece · 5 positions across 2 lenderslargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• P•••••• C••••• F•••• L•• | term loan first lien Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 6.50% I••••••• R••• 10.23% A••••••••• D | $3.3M | $3.3M 100c | SOFR+650 bp |
| A•••• C••••• B•• I••• | term loan first lien Investment T••• U••••••••• T••• L••• I•••• S+ S••••• 6.50% I••••••• R••• 10.23% A••••••••• | $1.6M | $1.6M 100c | SOFR+650 bp |
| A•••• C••••• B•• I••• | equity equity Investment T••• C•••• A U•••• A••••••••• D••• 12/15/2025 | Not disclosed | $998,244 45c | |
| A•••• P•••••• C••••• F•••• L•• | preferred equity equity Investment T••• C••••• Equity and P•••••••• S••••• | Not disclosed | $2.0M | |
| A•••• P•••••• C••••• F•••• L•• | unstated lien unstated Investment T••• B••• L•••• | Not disclosed | $3.3M |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $4.9M | 100c | SOFR+650 bp | Dec 15, 2031 | 2 |
| other lien unstated | unknown | n/a | unstated | 2 | |
| revolver lien unstated exited Sep 30, 2025 | at least $1.8M | 90c | SOFR+650 bp | Dec 24, 2029 | 1 |
| first lien revolver first lien exited Sep 30, 2025 | at least $863,931 | 91c | SOFR+650 bp | Dec 22, 2028 | 1 |
Equity pieces beside the debt: preferred equity ($2.0M fair value, 1 BDC), equity ($998,244 fair value, 1 BDC)
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 2 | $4.9M | $4.9M | 100c | 0 |
| Mar 31, 2026 | 2 | $4.9M | $4.9M | 100c | 0 |
| Dec 31, 2025 | 2 | $11.4M | $11.4M | 100c | 0 |
| Sep 30, 2025 | 2 | $11.6M | $10.4M | 90c | 0 |
All 5 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Dec 31, 2024 | 1 | $12.2M | $12.1M | 100c | 0 |
What changed
- Lender left a facilityMar 31, 2026
- Maturity extended (observed)Dec 31, 2025
- Mark recoveredDec 31, 2025
- New lender joined a facilityDec 31, 2025
- Maturity extended (observed)Dec 31, 2025
Full timeline · 8 eventsShow fewer
- New lender joined a facilitySep 30, 2025
- Facility left every BDC scheduleSep 30, 2025
- Facility left every BDC scheduleSep 30, 2025
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- VISORderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 2 BDCsderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it